Federation des caisses Desjardins du Quebec’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio QNTM Stock Details QNTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$369	Hold	93	–	–	﹤0.01%	2837
2025 Q4	$657	Buy	93 +1	+1%	+$11	﹤0.01%	2712
2025 Q3	$1.49K	Buy	92 +64	+229%	+$1.26K	﹤0.01%	2629
2025 Q2	$552	Hold	28	–	–	﹤0.01%	2560
2025 Q1	$209	Hold	28	–	–	﹤0.01%	2564
2024 Q4	$101	Buy	28 +14	+100%	+$66	﹤0.01%	2485
2024 Q3	$55	Buy	14 +2	+17%	+$12	﹤0.01%	2516
2024 Q2	$123	Hold	12	–	–	﹤0.01%	2371
2024 Q1	$744	Hold	12	–	–	﹤0.01%	2212
2023 Q4	$711	Hold	12	–	–	﹤0.01%	2175
2023 Q3	$948	Hold	12	–	–	﹤0.01%	2156
2023 Q2	$883	Sell	12 -1	-8%	-$86	﹤0.01%	2145
2023 Q1	$1.34K	Hold	13	–	–	﹤0.01%	2127
2022 Q4	$666	Hold	13	–	–	﹤0.01%	2326
2022 Q3	$683	Hold	13	–	–	﹤0.01%	2382
2022 Q2	$674	Sell	13 -1	-7%	-$60	﹤0.01%	2422
2022 Q1	$765	Buy	14 +1	+8%	+$61	﹤0.01%	2455
2021 Q4	$878	Hold	13	–	–	﹤0.01%	2429
2021 Q3	$1.31K	Buy	13 +1	+8%	+$107	﹤0.01%	2442
2021 Q2	$1.41K	Hold	12	–	–	﹤0.01%	2416
2021 Q1	$1.49K	Hold	12	–	–	﹤0.01%	2344
2020 Q4	$1.25K	Hold	12	–	–	﹤0.01%	2221
2020 Q3	$2.03K	Hold	12	–	–	﹤0.01%	2005
2020 Q2	$3.04K	Sell	12 -1	-8%	-$234	﹤0.01%	1893
2020 Q1	$2.97K	Buy	+13	New	+$4.31K	﹤0.01%	1935

Other funds holding QNTM

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

PTP

Platform Technology Partners New York $611M AUM 25.5% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's QNTM Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec held its Quantum Biopharma Class B Subordinate Voting Shares (QNTM) position steady in Q1 2026 at 93 shares worth $369. The position accounts for ﹤0.01% of the portfolio, ranked #2837.

Federation des caisses Desjardins du Quebec first reported a position in QNTM in Q1 2020 and has held it in 25 quarters since. The position peaked at $3.04K in Q2 2020. 25 funds tracked by Wall St. Rank hold QNTM as of Q1 2026.

Federation des caisses Desjardins du Quebec held 93 shares of Quantum Biopharma Class B Subordinate Voting Shares worth $369 as of Q1 2026.
Federation des caisses Desjardins du Quebec left its Quantum Biopharma Class B Subordinate Voting Shares share count unchanged in Q1 2026.
Quantum Biopharma Class B Subordinate Voting Shares made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #2837 holding.
Federation des caisses Desjardins du Quebec first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q1 2020 and has held it in 25 quarters since.
Federation des caisses Desjardins du Quebec's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $3.04K in Q2 2020.
25 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.